Loading company…
Pharmatest Services provides preclinical research and efficacy models for cancer and skeletal diseases.
Founded in 1998 by Jussi Halleen, Pharmatest Services is a preclinical contract research organization focused on cancer and skeletal diseases. It supports early drug development with in vitro and in vivo testing, biomarker analysis, histology, cell-based assays and screening. The company is based in Turku, Finland. Innovestor invested in June 2016; as of March 2023, its CEO was Jukka Rissanen.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in